| P50 | author | Mary Jeanne Kreek | Q21531361 |
| | George Koob | Q5541413 |
| P2860 | cites work | An opponent-process theory of motivation: I. Temporal dynamics of affect. | Q29544435 |
| | Drug abuse: hedonic homeostatic dysregulation | Q29615904 |
| | Drug addiction, dysregulation of reward, and allostasis | Q29616741 |
| | Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats | Q30486793 |
| | Ketoconazole reduces low dose cocaine self-administration in rats | Q31424140 |
| | Effect of repeated exposure to alcohol on the response of the hypothalamic-pituitary-adrenal axis of the rat: I. Role of changes in hypothalamic neuronal activity | Q31993935 |
| | Microarray studies of psychostimulant-induced changes in gene expression | Q33214334 |
| | The role of the striatopallidal and extended amygdala systems in drug addiction | Q33692839 |
| | Corticotropin-releasing factor, norepinephrine, and stress | Q33772693 |
| | A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. | Q33804777 |
| | Excessive ethanol drinking following a history of dependence: animal model of allostasis | Q33900052 |
| | The role of CRH in behavioral responses to stress | Q33945501 |
| | Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine | Q33981475 |
| | Narcotic blockade | Q34203445 |
| | The role of corticotropin-releasing factor in drug addiction. | Q34253441 |
| | Drug addictions. Molecular and cellular endpoints. | Q34310836 |
| | Stress and cocaine addiction | Q34649304 |
| | Nicotine addiction: insights from recent animal studies | Q34732274 |
| | Pharmacotherapy of addictions | Q34810395 |
| | History and current status of opioid maintenance treatments: blending conference session | Q34830836 |
| | The orphanin FQ/nociceptin knockout mouse: a behavioral model for stress responses | Q34930363 |
| | Nibbling at CRF receptor control of feeding and gastrocolonic motility | Q35198041 |
| | Rationale for maintenance pharmacotherapy of opiate dependence | Q35250814 |
| | Neuroadaptive mechanisms of addiction: studies on the extended amygdala | Q35592711 |
| | Genes associated with addiction: alcoholism, opiate, and cocaine addiction | Q35682961 |
| | Neurobiological mechanisms in the transition from drug use to drug dependence. | Q35690527 |
| | The therapeutic potential of CRF1 antagonists for anxiety | Q35814456 |
| | Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation. | Q35857320 |
| | Evolving perspectives on neurobiological research on the addictions: celebration of the 30th anniversary of NIDA. | Q35908748 |
| | Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments | Q36056325 |
| | Chemical and Biological Characterization of Corticotropin Releasing Factor | Q40138196 |
| | Corticotropin-releasing factor and neuropeptide Y: role in emotional integration | Q40388139 |
| | Effect of ethanol on the regulation of corticotropin-releasing factor (CRF) gene expression | Q40417859 |
| | Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons | Q41048190 |
| | Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models | Q41277218 |
| | Interchangeability of stress and amphetamine in sensitization | Q41630062 |
| | The role of stress in drug self-administration | Q41742771 |
| | Restraint-induced corticosterone secretion and hypothalamic CRH mRNA expression are augmented during acute withdrawal from chronic cocaine administration | Q42182138 |
| | Transition from moderate to excessive drug intake: change in hedonic set point. | Q42539135 |
| | Drug dependence: stress and dysregulation of brain reward pathways | Q43070756 |
| | Predictable individual differences in the initiation of cocaine self-administration by rats under extended-access conditions are dose-dependent | Q43712172 |
| | Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol | Q43843287 |
| | Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats | Q43858305 |
| | Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. | Q44021767 |
| | Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor | Q44190199 |
| | Subject-regulated dosing alters morphine self-administration behavior and morphine-stimulated [35S]GTPgammaS binding | Q44285756 |
| | Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal | Q44332580 |
| | Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. | Q44369585 |
| | Escalation of cocaine self-administration does not depend on altered cocaine-induced nucleus accumbens dopamine levels. | Q44478498 |
| | Neuroendocrine alterations in a high-dose, extended-access rat self-administration model of escalating cocaine use. | Q44533507 |
| | Effects of extended access to high versus low cocaine doses on self-administration, cocaine-induced reinstatement and brain mRNA levels in rats | Q44813123 |
| | Decreased plasma membrane targeting of NMDA-NR1 receptor subunit in dendrites of medial nucleus tractus solitarius neurons in rats self-administering morphine | Q44987909 |
| | Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure | Q45152845 |
| | Plasticity of reward neurocircuitry and the 'dark side' of drug addiction | Q46177203 |
| | An initial, three-day-long treatment with alcohol induces a long-lasting phenomenon of selective tolerance in the activity of the rat hypothalamic-pituitary-adrenal axis. | Q46338303 |
| | Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. | Q46529874 |
| | Frequency of recent cocaine and alcohol use affects drug craving and associated responses to stress and drug-related cues. | Q46564345 |
| | Unlimited access to heroin self-administration: independent motivational markers of opiate dependence | Q46923752 |
| | Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes | Q46977972 |
| | 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. | Q48250731 |
| | Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression | Q48507105 |
| | Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats | Q48903690 |
| | Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis | Q49113846 |
| | Effects of cocaine self-administration on plasma corticosterone and prolactin in rats. | Q51393878 |
| | Ketoconazole blocks the stress-induced reinstatement of cocaine-seeking behavior in rats: relationship to the discriminative stimulus effects of cocaine. | Q51461432 |
| | Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? | Q68166537 |
| | Adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in alcohol dependence disorder. Preliminary report | Q69348983 |
| | Response of ACTH and cortisol to human corticotropin-releasing hormone after short-term abstention from alcohol abuse | Q69833885 |
| | Response of dehydroepiandrosterone to corticotropin-releasing hormone stimulation in alcohol-dependent subjects | Q71871889 |
| | Persistent increase in the motivation to take heroin in rats with a history of drug escalation | Q73505941 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | drug dependence | Q3541786 |
| | substance dependence | Q3378593 |
| P304 | page(s) | 1149-59 | |
| P577 | publication date | 2007-08-01 | |
| P1433 | published in | American Journal of Psychiatry | Q1935368 |
| P1476 | title | Stress, dysregulation of drug reward pathways, and the transition to drug dependence | |
| P478 | volume | 164 | |